Long-term cost-effectiveness of early and sustained dual oral antiplatelet therapy with clopidogrel following percutaneous coronary intervention (CREDO trial): A four-European country analysis Conference

Weintraub, WS, Bouin, O, Veledar, E et al. (2005). Long-term cost-effectiveness of early and sustained dual oral antiplatelet therapy with clopidogrel following percutaneous coronary intervention (CREDO trial): A four-European country analysis . VALUE IN HEALTH, 8(3), 262-262. 10.1016/S1098-3015(10)62647-2

Open Access Industry Collaboration International Collaboration

keywords

  • Business & Economics
  • Economics
  • Health Care Sciences & Services
  • Health Policy & Services
  • Life Sciences & Biomedicine
  • Science & Technology
  • Social Sciences

Digital Object Identifier (DOI)

publisher

  • BLACKWELL PUBLISHING INC

start page

  • 262

end page

  • 262

volume

  • 8

issue

  • 3